Prevalence and factors associated with diabetic retinopathy among type 2 diabetic patients in Bangladesh: a hospital based cross-sectional study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20223529Keywords:
Diabetes, Diabetic retinopathy, Drug adherence, Fundus photographyAbstract
Background: Diabetes mellitus is a major health problem in Southeast Asia and diabetic retinopathy is one of its most debilitating complications. Nevertheless, fundoscopy and systematic evaluation of non-adherence to drug therapy are not regularly done in individuals with diabetes in Bangladesh due to limited resources. Therefore, the prevalence of diabetic retinopathy and its determinants with non-adherence to drug therapy are not known. We, therefore, screened for diabetic retinopathy, non-adherence to drug therapy and other associated factors at a tertiary care hospital in Bangladesh.
Methods: Between May 2017 to September 2017, we conducted a cross-sectional study of 489 systematically recruited asymptomatic, at least one-year type-2 diabetic individuals on medication and attending the outpatient department of the BIHS tertiary care centre in Dhaka, Bangladesh. We obtained a medical history, physical examination, routine laboratory tests, questionnaires, and fundus photography.
Results: The prevalence of diabetic retinopathy among T2DM patients was 18.8%. Clinical factors associated with the presence of diabetic retinopathy were uncontrolled fasting blood glucose, known duration of diabetes of ≥10 years and self-reported non-adherence to drug therapy. With a known duration of diabetes of 15 years or more, the prevalence of diabetic retinopathy rose to 40%.
Conclusions: Undiagnosed diabetic retinopathy is still common among patients in Bangladesh, even at tertiary care centres. It is associated with longer disease duration, poor metabolic control and self-reported non-adherence to therapy. Regular screening for diabetic retinopathy should therefore be implemented also in resource-limited settings and further efforts should be made to improve the patients’ drug adherence and metabolic control.
Metrics
References
World Health Organization. Global Report on Diabetes. Isbn. 2016;978:88.
Congdon NG, Friedman DS, Lietman T. Important Causes of Visual Impairment in the World Today. J. Am. Med. Assoc. 2003;290(15):2057-60.
Romero-aroca P, Sagarra-alamo R, Pareja-rios A, López M. Importance of Telemedicine in Diabetes Care : Relationships between Family Physicians and Ophthalmologists Importance of Telemedicine in Diabetes Care : Relationships between Family Physicians and Ophthalmologists. World J Diabetes. 2015;6(8):1005.
Drake L. Prevention of Blindness from Diabetes Mellitus – Report of a Who Consultation in Geneva, Switzerland,9-11 November 2005. Nurs. Stand. (through 2013). 2007;21(32):30.
Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412-8.
López M, Cos FX, Álvarez-Guisasola F, Fuster E. Prevalence of Diabetic Retinopathy and Its Relationship with Glomerular Filtration Rate and Other Risk Factors in Patients with Type 2 Diabetes Mellitus in Spain. DM2 HOPE Study J Clin Transl Endocrinol. 2017;9:61-5.
Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA, Polak BCP. Blood Pressure, Lipids, and Obesity Are Associated with Retinopathy: The Hoorn Study. Diabetes Care 2002;25(8):1320-5.
Rajala U, Laakso M, Qiao Q, Keinänen-Kiukaanniemi S. Prevalence of Retinopathy in People with Diabetes, Impaired Glucose Tolerance, and Normal Glucose Tolerance. Diabetes Care. 1998;21(10):1964–9.
Islam SMS, Alam DS, Wahiduzzaman M, Niessen LW, Froeschl G, Ferrari U, et al. Clinical Characteristics and Complications of Patients with Type 2 Diabetes Attending an Urban Hospital in Bangladesh. Diabetes Metab. Syndr. 2015;9(1):7-13.
Wahiduzzaman M, Hossain S, Islam SM, Banning F, Ali L, Lechner A. Knowledge on Diabetes and Its Determinants among Type 2 Diabetic Subjects in a Low-Resource Setting: A Cross-Sectional Study in a Tertiary Care Hospital in Bangladesh. J. Diabetol. 2021;12(3):299.
View W. Prevalence and Causes of Blindness and Visual Impairment in Bangladeshi Adults: Results of the National Blindness and Low Vision Survey of Bangladesh. Br. J. Ophthalmol. 2003;87(7):820-8.
Akhter A, Fatema K, Ahmed SF, Afroz A, Ali L, Hussain A. Prevalence and Associated Risk Indicators of Retinopathy in a Rural Bangladeshi Population with and without Diabetes. Ophthalmic Epidemiol. 2013;20(4):220-7.
Ahmed KR, Karim MN, Bhowmik B, Habib SH, Bukht MS, Ali L, et al. Incidence of Diabetic Retinopathy in Bangladesh: A 15-Year Follow-up Study. J. Diabetes 2012;4(4):386-91.
Ghanchi F, Bailey C, Chakravarthy U, Cohen S, Dobson P, Gibson J, et al. The Royal College of Ophthalmologists Diabetic Retinopathy Guidelines. Diabet. Retin. Guidel. 2012;2:1-47.
Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, et al. Diabetic Retinopathy Preferred Practice Pattern®. Ophthalmology. 2020;127(1):66-145.
Jannuzzi FF, Cintra FA, Rodrigues RCM, São-João TM, Gallani MCBJ. Medication Adherence and Quality of Life among the Elderly with Diabetic Retinopathy. Rev. Lat. Am. Enfermagem. 2014;22(6):902-10.
Mohiuddin AK. Diabetes Fact: Bangladesh Perspective. Int. J. Diabetes Res. 2019;2(1):14-20.
Olson JA, Strachan FM, Hipwell JH, Goatman KA, McHardy KC, Forrester JV. A Comparative Evaluation of Digital Imaging, Retinal Photography and Optometrist Examination in Screening for Diabetic Retinopathy. Diabet Med. 2003;20(7):528-34.
Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed International Clinical Diabetic Retinopathy and Diabetic Macular Edema Disease Severity Scales. Ophthalmology. 2003;110(9):1677-82.
Saleh F, Mumu SJ, Ara F, Hafez MA, Ali L. Non-Adherence to Self-Care Practices & Medication and Health Related Quality of Life among Patients with Type 2 Diabetes: A Cross-Sectional Study. BMC Public Health. 2014;14(1):431.
Mumu S, Saleh F, Ara F, Afnan F, Ali L. Non-Adherence to Life-Style Modification and Its Factors among Type 2 Diabetic Patients. Indian J. Public Health. 2014;58(1):40.
Mumu SJ, Merom D, Ali L, Fahey PP, Hossain I, Rahman AKMF, Allman-Farinelli M. Validation of a Food Frequency Questionnaire as a Tool for Assessing Dietary Intake in Cardiovascular Disease Research and Surveillance in Bangladesh. Nutr. J. 2020;19:42.
Schröder H, Covas MI, Marrugat J, Vila J, Pena A, Alcántara M, et al. Use of a Three-Day Estimated Food Record, a 72-Hour Recall and a Food-Frequency Questionnaire for Dietary Assessment in a Mediterranean Spanish Population. Clin. Nutr. 2001;20(5):429-37.
Paudyal G, Shrestha MK, Meyer JJ, Thapa R, Gurung R, Ruit S. Prevalence of Diabetic Retinopathy Following a Community Screening for Diabetes. Nepal Med. Coll. J. 2008;10(3):160–3.
Weerasuriya N, Siribaddana S, Dissanayak, A, Subasinghe Z, Wariyapola D, Fernando DJS. Long-Term Complications in Newly Diagnosed Sri Lankan Patients with Type 2 Diabetes Mellitus. QJM - Mon. J. Assoc. Physicians. 1998;91(6):439-43.
Iqbal T, Zafar J. Frequency of Retinopathy in Newly Diagnosed Type 2 Diabetes Mellitus. Rawal Med J. 2009;34(2):167-9.
Ballard DJ, Melton LJ, Dwyer MS, Trautmann JC, Chu CP, O’Fallon WM. Risk Factors for Diabetic Retinopathy: A Population-Based Study in Rochester, Minnesota. Diabetes Care. 1986;9(4):334-42.
Klein R, Klein BEK, Moss SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The Relationship of C-Peptide to the Incidence and Progression of Diabetic Retinopathy. Diabetes. 1995;44(7):796-801.
Wilkinson-Berka J. Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide. Curr Pharm Des. 2005;10(27):3331-48.
He B-B, Wei L, Gu Y-J, Han J-F, Li M, Liu Y-X. Factors Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus. Int. J. Endocrinol. 2012:42:1-8.
Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and Risk Factors for Diabetic Neuropathy in an Urban South Indian Population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med. 2008;25(4):407-12.
Rubin RR, Peyrot M. Psychological Issues and Treatments for People with Diabetes. J Clin Psychol. 2001;57(4):457-78.
Ahmed KR, Karim MN, Bukht MS, Bhowmik B, Acharyya A, Ali L. Risk Factors of Diabetic Retinopathy in Bangladeshi Type 2 Diabetic Patients. Diabetes Metab Syndr Clin Res Rev. 2011;5(4):196-200.
Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y. The Effect of Fasting Plasma Glucose Variability on the Risk of Retinopathy in Type 2 Diabetic Patients: Retrospective Long-Term Follow-Up. Diabetes Res. Clin. Pract. 2010;89(3):296-302.
Gimeno-Orna, JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM. Fasting Plasma Glucose Variability as a Risk Factor of Retinopathy in Type 2 Diabetic Patients. J. Diabetes Complications. 2003;17(2):78-81.
Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: A Tool for Screening Patient Adherence and Barriers to Adherence. Patient Educ Couns. 1996;37(2):113-24.
Ishaq H, Ali M, Kazmi N, Naqvi BS, Shaikh D. Prevalence of Diabetic Retinopathy in Type II Diabetic Patients in a Health Facility in Karachi, Pakistan. Trop J Pharm Res. 2016;15(5):1069-76.
Lau HS, Beuning KS, Postma-Lim E, Klein-Beernink L, De Boer A, Porsius AJ. Non-Compliance in Elderly People: Evaluation of Risk Factors by Longitudinal Data Analysis. Pharm World Sci. 1996;18(2):63-8.
Downloads
Published
How to Cite
Issue
Section
